We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Ozelle Demonstrates AI-Powered Diagnostic Workflows at WHX Labs Dubai 2026

By LabMedica International staff writers
Posted on 11 Feb 2026

At WHX Labs Dubai 2026, Ozelle is exhibiting its advanced diagnostic workflow solution under the theme “AI × CBM: The Next Generation of Complete Blood Morphology. More...

” The system is designed to support decision-ready laboratory workflows by integrating high-resolution morphology imaging, AI-assisted analysis, and scenario-specific diagnostic panels.

Central to the on-site demonstrations is the Intelligent AI Workbench (Open Dx), a unified diagnostic workspace embedded within the analyzer. It converts raw laboratory results into structured, interactive insights, guiding clinicians through actionable information.

Key features include risk stratification, conversational AI report interpretation, critical alerts, and follow-up trend analysis. By integrating test ordering, result review, and AI-assisted interpretation into a single, intuitive workflow, the workbench supports confident, efficient decisions without adding operational burden or extensive training.

Live demonstrations at the exhibition highlight the system’s versatility across multiple clinical scenarios, including infection profiling with combined CBC, CRP, and SAA testing in a single fully automated run without manual reagent switching. The platform also supports everyday disease management through flexible, customizable panels for diabetes, cardiac, and thyroid monitoring, enabling repeatable, high-frequency testing without added workflow complexity. 

In addition, AI-powered morphology analysis for malaria risk screening detects red blood cell patterns associated with Plasmodium, delivering high-, medium-, and low-risk indications to support early screening and follow-up in endemic regions. Together, these scenario-ready capabilities show how Ozelle extends advanced morphology intelligence beyond routine CBC to address both everyday clinical care and high-risk public health needs.

At the foundation of Ozelle's system is AI-powered Complete Blood Morphology (CBM), which combines high-resolution imaging with real-time algorithmic analysis for deeper, actionable insights. Combined with a maintenance-free, easy-to-use device design, the system delivers long-term reliability, ideal for primary care clinics, chain laboratories, and decentralized testing sites.

Ozelle's technology is validated through 50,000+ global installations, generating 50 million+ cell images daily and over 100 billion real-world data points. Continuous algorithm refinement via an industry-exclusive quality control system ensures lab-grade performance that remains stable, scalable, and sustainable over time. 

Related Links:
Ozelle


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Microbiology

view channel
Image: Graphical Abstract (Emery, J. K., V. Nemidkanam, N. Colon, et al. Journal of Extracellular Vesicles (2026). https://doi.org/10.1002/jev2.70286)

Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.